Literature DB >> 18201556

Production of human erythropoietin by chimeric chickens.

Daisuke Kodama1, Daisuke Nishimiya, Ken-Ichi Iwata, Kazuhisa Yamaguchi, Kazuhiro Yoshida, Yoshinori Kawabe, Makoto Motono, Hiroyuki Watanabe, Takashi Yamashita, Ken-Ichi Nishijima, Masamichi Kamihira, Shinji Iijima.   

Abstract

The use of transgenic avian allows cost effective and safe production of pharmaceutical proteins. Here, we report the successful production of chimeric chickens expressing human erythropoietin (hEpo) using a high-titer retroviral vector. The hEpo expressed by transgenic hens accumulated abundantly in egg white and had N- and O-linked carbohydrates. While attachment of terminal sialic acid and galactose was incomplete, portions of N- and O-linked carbohydrates were present. In vitro biological activity of egg white-hEpo was comparable to that produced by recombinant CHO cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201556     DOI: 10.1016/j.bbrc.2008.01.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Avian Bioreactor Systems: A Review.

Authors:  Rachel M Woodfint; Erin Hamlin; Kichoon Lee
Journal:  Mol Biotechnol       Date:  2018-12       Impact factor: 2.695

2.  Genetic modification of a chicken expression system for the galactosylation of therapeutic proteins produced in egg white.

Authors:  Akifumi Mizutani; Hiroyuki Tsunashima; Ken-ichi Nishijima; Takako Sasamoto; Yuki Yamada; Yasuhiro Kojima; Makoto Motono; Jun Kojima; Yujin Inayoshi; Katsuhide Miyake; Enoch Y Park; Shinji Iijima
Journal:  Transgenic Res       Date:  2011-04-13       Impact factor: 2.788

3.  Expression of interferon-inducible transmembrane proteins in the chicken and possible role in prevention of viral infections.

Authors:  Shunsuke Kidani; Yuya Okuzaki; Hidenori Kaneoka; Seiya Asai; Seitaro Murakami; Yusuke Murase; Shinji Iijima; Ken-Ichi Nishijima
Journal:  Cytotechnology       Date:  2016-04-27       Impact factor: 2.058

4.  Recombinant proteins produced into yolk of genetically manipulated chickens are partly sialylated in N-glycan.

Authors:  Kazuhiro Yoshida; Yuya Okuzaki; Ken-Ichi Nishijima; Kenji Kyogoku; Takashi Yamashita; Yoshinori Kawabe; Makoto Motono; Masamichi Kamihira; Shinji Iijima
Journal:  Cytotechnology       Date:  2013-07-19       Impact factor: 2.058

5.  Efficient production of transgenic chickens based on piggyBac.

Authors:  Xiaojuan Liu; Ning Li; Xiaoxiang Hu; Ran Zhang; Qingyuan Li; Dainan Cao; Tongxin Liu; Yaqiong Zhang; Xiaofang Liu
Journal:  Transgenic Res       Date:  2012-08-24       Impact factor: 2.788

6.  Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens.

Authors:  Carlos Alberto Penno; Yoshinori Kawabe; Akira Ito; Masamichi Kamihira
Journal:  Transgenic Res       Date:  2009-08-04       Impact factor: 2.788

7.  Tetracycline-dependent expression of the human erythropoietin gene in transgenic chickens.

Authors:  Bon Chul Koo; Mo Sun Kwon; Hyuna Lee; Minjee Kim; Dohyang Kim; Ji Yeol Roh; Yoon-Yub Park; Xiang-Shun Cui; Nam-Hyung Kim; Sung June Byun; Teoan Kim
Journal:  Transgenic Res       Date:  2009-10-01       Impact factor: 2.788

8.  Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens.

Authors:  Yoshinori Kawabe; Yuuki Hayashida; Kensaku Numata; Shota Harada; Yoshifumi Hayashida; Akira Ito; Masamichi Kamihira
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

9.  Genetic modification of chicken germ cells.

Authors:  Tae Sub Park; Jae Yong Han
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

10.  Cre-LoxP-regulated expression of monoclonal antibodies driven by an ovalbumin promoter in primary oviduct cells.

Authors:  Isao Oishi; Sungtae Kim; Kyoko Yoshii; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  BMC Biotechnol       Date:  2011-01-14       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.